NDA Partners Expands Pediatric Clinical Pharmacology Expertise
Washington, DC (PRWEB) September 01, 2022 -- NDA Partners’ General Manager, Eric Fish, announced today that the firm has strengthened its clinical
Source: prweb.com
Page 2 - Model Informed Drug Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Model Informed Drug Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Model Informed Drug Development Today - Breaking & Trending Today
Anebulo's Cannabinoid Intoxication Reversal Agent Effective in Netherlands Study
The Phase II study, conducted in the Netherlands, evaluated the single-dose ANEB-001 in treating healthy participants affected by THC. Anebulo plans to file an IND with the FDA by the end of 2022.
Source: biospace.com
Drug Development in the Metaverse | ArentFox Schiff
“Metaverse” is no longer a mere buzzword. Many industries are discovering and developing applications for the Metaverse, and the pharma and biotech industry is no different.
Source: jdsupra.com
Dr. Nidal Huniti joins A2PG as President
/PRNewswire/ -- A2PG and Amador Bioscience announced today that Dr. Nidal Huniti has joined the company as President of A2PG. Dr. Huniti, a veteran of the...
Source: prnewswire.com
Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced record-setting attendance and virtual
Source: sharewise.com